Advertisement
Research Article

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal

  • Elena Losina mail,

    elosina@partners.org

    Affiliations: Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America

    X
  • Hapsatou Touré,

    Affiliation: INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France

    X
  • Lauren M. Uhler,

    Affiliation: Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America

    X
  • Xavier Anglaret,

    Affiliations: INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France, Centre de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire

    X
  • A. David Paltiel,

    Affiliation: Yale University, New Haven, Connecticut, United States of America

    X
  • Eric Balestre,

    Affiliation: INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France

    X
  • Rochelle P. Walensky,

    Affiliations: Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America, Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Center for AIDS Research, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Eugène Messou,

    Affiliation: Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America

    X
  • Milton C. Weinstein,

    Affiliation: Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America

    X
  • François Dabis,

    Affiliation: INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France

    X
  • Kenneth A. Freedberg,

    Affiliations: Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America, INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France, Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America, Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America, Center for AIDS Research, Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America

    X
  • for the ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA),
  • and the CEPAC International investigators
  • Published: October 27, 2009
  • DOI: 10.1371/journal.pmed.1000173

About the Authors

Elena Losina, Lauren M. Uhler, Rochelle P. Walensky, Kenneth A. Freedberg
Division of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America
Elena Losina
Department of Orthopedic Surgery, Brigham and Women's Hospital, Boston, Massachusetts, United States of America
Elena Losina
Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America
Hapsatou Touré, Xavier Anglaret, Eric Balestre, Rochelle P. Walensky, François Dabis, Kenneth A. Freedberg
INSERM U897, Institut de Santé Publique d'Epidémiologie et de Développement (ISPED), Université Victor Segalen, Bordeaux, France
Xavier Anglaret
Centre de Prise en charge, de Recherche et de Formation (CePReF), Abidjan, Côte d'Ivoire
A. David Paltiel
Yale University, New Haven, Connecticut, United States of America
Rochelle P. Walensky, Milton C. Weinstein, Kenneth A. Freedberg
Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America
Rochelle P. Walensky, Kenneth A. Freedberg
Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, United States of America
Rochelle P. Walensky, Kenneth A. Freedberg
Center for AIDS Research, Harvard Medical School, Boston, Massachusetts, United States of America
Eugène Messou
Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America
Kenneth A. Freedberg
Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America

Corresponding Author

Email: elosina@partners.org

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

ICMJE criteria for authorship read and met: EL HT LMU XA ADP EB RPW EM MCW FD KAF. Agree with the manuscript's results and conclusions: EL HT LMU XA ADP EB RPW EM MCW FD KAF. Designed the experiments/the study: EL HT XA FD. Analyzed the data: EL RPW KAF. Collected data/did experiments for the study: HT XA. Wrote the first draft of the paper: EL HT. Contributed to the writing of the paper: EL LMU XA ADP RPW MCW FD KAF. Conducted model analyses: LMU. Assisted in model development and updating: ADP. Provided methodologic guidance and helped developed the model: MCW. Co-developed the model: KAF.